118 related articles for article (PubMed ID: 11986255)
21. Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen.
de Quiros JC; Shupert WL; McNeil AC; Gea-Banacloche JC; Flanigan M; Savage A; Martino L; Weiskopf EE; Imamichi H; Zhang YM; Adelsburger J; Stevens R; Murphy PM; Zimmerman PA; Hallahan CW; Davey RT; Connors M
J Virol; 2000 Feb; 74(4):2023-8. PubMed ID: 10644376
[TBL] [Abstract][Full Text] [Related]
22. Complement and virus-specific antibody-dependent infection of normal B lymphocytes by human immunodeficiency virus type 1.
Gras G; Richard Y; Roques P; Olivier R; Dormont D
Blood; 1993 Apr; 81(7):1808-18. PubMed ID: 8461467
[TBL] [Abstract][Full Text] [Related]
23. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
[TBL] [Abstract][Full Text] [Related]
24. Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.
Techakriengkrai N; Tansiri Y; Hansasuta P
AIDS; 2013 Jan; 27(1):17-27. PubMed ID: 23079801
[TBL] [Abstract][Full Text] [Related]
25. CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease.
Boritz E; Rapaport EL; Campbell TB; Koeppe JR; Wilson CC
Virology; 2007 Apr; 361(1):34-44. PubMed ID: 17169395
[TBL] [Abstract][Full Text] [Related]
26. Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.
Gorse GJ; Simionescu RE; Patel GB
Clin Vaccine Immunol; 2006 Jan; 13(1):26-32. PubMed ID: 16425996
[TBL] [Abstract][Full Text] [Related]
27. Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.
Roff SR; Sanou MP; Rathore MH; Levy JA; Yamamoto JK
Hum Vaccin Immunother; 2015; 11(6):1540-56. PubMed ID: 25844718
[TBL] [Abstract][Full Text] [Related]
28. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
[TBL] [Abstract][Full Text] [Related]
29. Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes.
Bass HZ; Fahey JL; Nishanian P; Detels R; Cumberland W; Kemeny M; Plaeger S
Clin Diagn Lab Immunol; 1997 Jan; 4(1):64-9. PubMed ID: 9008283
[TBL] [Abstract][Full Text] [Related]
30. Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs.
Brozy J; Schlaepfer E; Mueller CKS; Rochat MA; Rampini SK; Myburgh R; Raum T; Kufer P; Baeuerle PA; Muenz M; Speck RF
J Virol; 2018 Jul; 92(14):. PubMed ID: 29720517
[TBL] [Abstract][Full Text] [Related]
31. Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals.
Klein MR; Veenstra J; Holwerda AM; Roos MT; Gow I; Patou G; Coutinho RA; De Wolf F; Miedema F
AIDS Res Hum Retroviruses; 1997 Mar; 13(5):393-9. PubMed ID: 9075480
[TBL] [Abstract][Full Text] [Related]
32. Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir.
Kolber MA; Saenz MO; Kaul S
Clin Diagn Lab Immunol; 2005 Jan; 12(1):76-80. PubMed ID: 15642988
[TBL] [Abstract][Full Text] [Related]
33. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD
J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332
[TBL] [Abstract][Full Text] [Related]
34. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.
Rieckmann P; Poli G; Fox CH; Kehrl JH; Fauci AS
J Immunol; 1991 Nov; 147(9):2922-7. PubMed ID: 1918999
[TBL] [Abstract][Full Text] [Related]
35. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
36. Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.
Tarosso LF; Vieira VA; Sauer MM; Tomiyama HI; Kalil J; Kallas EG
AIDS Res Hum Retroviruses; 2017 Aug; 33(8):832-842. PubMed ID: 28594230
[TBL] [Abstract][Full Text] [Related]
37. Frequency of cells positive for HIV-1 p24 antigen assessed by flow cytometry.
Holzer TJ; Heynen CA; Novak RM; Pitrak DL; Dawson GJ
AIDS; 1993 Nov; 7 Suppl 2():S3-5. PubMed ID: 7909224
[TBL] [Abstract][Full Text] [Related]
38. The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy.
Binley JM; Schiller DS; Ortiz GM; Hurley A; Nixon DF; Markowitz MM; Moore JP
J Infect Dis; 2000 Apr; 181(4):1249-63. PubMed ID: 10762561
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogen.
Moss RB; Giermakowska WK; Wallace MR; Savary JR; Jensen FC; Carlo DJ
AIDS; 2000 Nov; 14(16):2475-8. PubMed ID: 11101057
[TBL] [Abstract][Full Text] [Related]
40. T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune).
Moss RB; Giermakowska W; Wallace MR; Savary J; Jensen F; Carlo DJ
Clin Diagn Lab Immunol; 2000 Sep; 7(5):724-7. PubMed ID: 10973444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
